Dow Down 0.62% Nasdaq Down 1.14%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
40.71 Down 1.57(3.71%) 4:00PM EDT
|After Hours : 40.16 Down 0.55 (1.35%) 7:25PM EDT
Prev Close:42.28
Open:42.04
Bid:40.10 x 1000
Ask:42.00 x 200
1y Target Est:45.50
Beta:1.67
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:39.68 - 42.21
52wk Range:22.25 - 62.66
Volume:1,923,615
Avg Vol (3m):1,952,760
Market Cap:4.79B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 3.71%4.79B
ENZDown 1.13%230.52M
GILDDown 0.46%159.44B
SRPTDown 4.55%850.79M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):32.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.75
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback